Apollo Endosurgery Inc Revenue Y/Y
What is the Revenue Y/Y of Apollo Endosurgery Inc?
The Revenue Y/Y of Apollo Endosurgery Inc is 22.01%
What is the definition of Revenue Y/Y?
Yearly revenue growth is the percentage growth of the company’s revenue over trailing twelve months.
= (revenue past four quarters - revenue previous four quarters) / revenue previous four quarters
The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.
Revenue Y/Y of companies in the Health Care sector on NASDAQ compared to Apollo Endosurgery Inc
What does Apollo Endosurgery Inc do?
Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo's device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo's products are offered in over 75 countries today and include the X-Tack™ Endoscopic HeliX Tacking System, the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.
Companies with revenue y/y similar to Apollo Endosurgery Inc
- Biocon has Revenue Y/Y of 21.97%
- Celestica has Revenue Y/Y of 21.97%
- Rayonier has Revenue Y/Y of 21.97%
- Chen Xing Development has Revenue Y/Y of 21.97%
- MS INTERNATIONAL plc has Revenue Y/Y of 22.01%
- Hormel Foods Dl ,01465 has Revenue Y/Y of 22.01%
- Apollo Endosurgery Inc has Revenue Y/Y of 22.01%
- Barnes has Revenue Y/Y of 22.02%
- Rane Engine Valve has Revenue Y/Y of 22.02%
- DoubleVerify has Revenue Y/Y of 22.03%
- Vertex Pharmaceuticals has Revenue Y/Y of 22.03%
- Immutep has Revenue Y/Y of 22.05%
- Immutep has Revenue Y/Y of 22.05%